Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RD

Robert Dally — 15 Patents

Eli Lilly: 9 patents #393 of 2,858Top 15%
BHBayer Healthcare: 2 patents #3,312 of 8,007Top 45%
BPBayer Pharmaceuticals: 2 patents #71 of 188Top 40%
MIMiles: 2 patents #135 of 626Top 25%
OPOnyx Pharmaceuticals: 1 patents #25 of 77Top 35%
Branford, CT: #35 of 367 inventorsTop 10%
Connecticut: #2,943 of 34,797 inventorsTop 9%
Overall (All Time): #307,048 of 4,157,543Top 8%
15 Patents All Time
Robert Dally has been granted 15 US patents while listed as an inventor at Eli Lilly. The first was granted in 1997 and the most recent in June 2021. Robert Dally ranks #307,048 of 4,157,543 US inventors in our database (top 7.4%). Patent records list Robert Dally in Branford, CT, US.

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11028074 CD73 inhibitors Maria Cristina Garcia Paredes, Lawrence Joseph Heinz, Jennifer Marie Howell, Frank George Njoroge, Yan Wang +1 more 2021-06-08 $1,981,836,000
9776992 1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers Harold Burns Brooks, Timothy Barrett Durham, Kevin Robert Fales, Kwame Frimpong, Jefferson Ray McCowan +6 more 2017-10-03 $235,090,000
9156824 CDC7 inhibitors Timothy Andrew Woods 2015-10-13 $236,599,000
8217032 Selective estrogen receptor modulators for the treatment of vasomotor symptoms Jeffrey A. Dodge, Scott Alan Frank, Ronald Jay Hinklin, Timothy Alan Shepherd, Owen Brendan Wallace 2012-07-10 $71,763,000
8148387 AKT and P70 S6 kinase inhibitors Timothy Alan Shepherd, Sajan Joseph 2012-04-03 $70,141,000
7863310 Kinase inhibitors Rosanne Bonjouklian, Alfonso De Dios, Mirian Filadelfa del Prado Catalina, Carmen Dominguez-Fernandez, Carlos Jaramillo Aguado +2 more 2011-01-04 $52,639,000
7745438 3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors Howard Barff Broughton, Timothy Barrett Durham, Maria Rosario Gonzalez-Garcia, Patric James Hahn, Kenneth J. Henry +5 more 2010-06-29 $59,946,000
7585977 Selective estrogen receptor modulators containing a phenylsulfonyl group Jeffrey A. Dodge, Scott Alan Frank, Scott Alan Jones, Timothy Alan Shepherd, Owen Brendan Wallace +3 more 2009-09-08 $83,913,000
7320995 Benzimidazoles and benzothiazoles as inhibitors of map kinase Rosanne Bonjouklian, Jose Eugenio De Diego Gomez, Alfonso De Dios, Chafiq Hamdouchi, Tiecho Li +11 more 2008-01-22 $46,193,000
6919371 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists Stephen O'Connor, Gaetan Ladouceur, William Bullock, Ann-Marie Campbell, Miao Dai +12 more 2005-07-19 $453,000
6660752 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists Stephen O'Connor, Gaetan Ladouceur, William Bullock, Ann-Marie Campbell, Miao Dai +12 more 2003-12-09 $1,144,000
6353006 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents Brian R. Dixon, Cedo Martin Bagi, Catherine Brennan, David R. Brittelli, William Bullock +11 more 2002-03-05 $317,000
6187799 Inhibition of raf kinase activity using aryl ureas Jill Wood, Hanno Wild, Daniel Rogers, John Francis Lyons, Michael Katz +4 more 2001-02-13 $6,460,000
5686469 Aminomethylene derivaties as immunosuppressants Richard Connell, David Osterman, Michael Katz 1997-11-11
5633277 Sulfonamide aminomethylene derivatives as immunosuppressants Richard Connell, David Osterman, Michael Katz 1997-05-27